Micro Emerging Active

GILD 加强炎症和自身免疫疾病管线，通过收购 Ouro Medicines

评分
0.4
动能
▲ 0.0
文章
4
来源
2

摘要

如果文章讨论了吉利德科学公司收购欧罗医药以加强其炎症和自身免疫疾病产品组合，则属于此叙事范畴。

相关文章

Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets

Yahoo Finance · 四月 04, 2026
Mixed

Gilead Sciences To Acquire Ouro Medicines

Nasdaq · 三月 24, 2026
Mixed

来源

Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines … Yahoo Finance
Gilead Sciences's Q1 2026 Earnings: What to Expect Yahoo Finance
Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation … Yahoo Finance
Gilead Sciences To Acquire Ouro Medicines Nasdaq

时间线

最后更新 三月 24, 2026